Danos Olivier 4
4 · REGENXBIO Inc. · Filed Apr 4, 2025
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Danos Olivier
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2025-02-01$8.07/sh−5,452$43,998→ 226,348 total
Footnotes (1)
- [F1]Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on February 1, 2025.